Latest Market News

Adveritas Limited has reported a record annualised recurring revenue of $12.2 million for the September 2025 quarter, driven by strong affiliate momentum and initial commercialisation of its Meta integration. The company is advancing its US expansion with a robust trial pipeline and expects significant contract conversions in the coming quarter.

Swift Networks has expanded its partnership with Uniting NSW to 25 aged care sites and introduced Swift TV at a major industry conference, positioning itself at the forefront of aged care technology innovation.

Middle Island Resources has appointed Daniel Raihani as Non-Executive Chairman to steer the company through its pivotal acquisition of Serbian copper-gold assets.

Corazon Mining has completed its acquisition of the Two Pools Gold Project, alongside a $2 million capital raise and a significant share consolidation, positioning itself for accelerated exploration in Western Australia’s prolific Gascoyne region.

RemSense Technologies has landed a pilot project with the Australian Gas Infrastructure Group to deploy its cutting-edge virtualplant platform, marking a key step into Australia’s gas transmission sector.

EROAD pivots strategically to prioritise ANZ electronic road user charging opportunities, revises FY26 guidance downward, and appoints John Scott as Executive Chair to steer growth.

TechGen Metals reports significant exploration progress with new high-grade copper and gold discoveries across multiple projects, supported by a successful $3.77 million capital raise. The company is poised to advance drilling programs amid strong commodity markets.

Lake Resources N.L. has released a replacement prospectus for its bonus loyalty options offer, adjusting key terms and updating its capital structure ahead of the 17 October record date. The offer aims to reward shareholders while potentially raising capital for its Kachi lithium project.

Alcidion Group Limited has reported a record FY25 with strong revenue growth, major NHS contract wins, and expanded AI capabilities in its Miya Precision platform, setting the stage for global healthcare IT expansion.

Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.

PainChek Limited has confirmed FDA De Novo classification for its PainChek Adult App, promptly disclosing the material regulatory milestone to the ASX and signalling a significant step towards US market entry.

IMDEX Limited reported a resilient FY25 with steady margins, reduced net debt, and strategic acquisitions positioning it for growth. The company’s FY26 outlook is optimistic, supported by improving global exploration activity and technology adoption.